Priority Review in Merkel Cell Carcinoma, Breakthrough Designation in RET-Altered Cancers, and More
3 Bekeken
• 07/17/23
0
0
insluiten
administrator
abonnees
Gina Columbus reports on a priority review designation in Merkel cell carcinoma, a breakthrough therapy designation in select RET-altered cancers, an application submitted in pediatric ALL, and European approvals in multiple myeloma, melanoma, and ALL.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties